Consolidated Balance Sheets - USD ($)	Dec. 31, 2019	Dec. 31, 2018
Current assets
Cash and cash equivalents	$ 12,581,136	$ 10,380,493
Restricted cash	110,000	110,000
Prepaid expenses	862,344	509,833
Research and development tax rebate receivable	739,656	518,098
Other current assets	26,130	30,942
Total current assets	14,319,266	11,549,366
Furniture and equipment, net	34,350	54,487
Intangible assets, net	68,542	99,375
Right-of-use asset	50,479
Other assets	17,218	17,218
Total Assets	14,489,855	11,720,446
Current liabilities
Accounts payable	293,171	353,328
Accrued expenses	77,888	177,074
Payroll liabilities	899,420	935,070
Stock-based compensation liability		1,410,025
Lease liability	39,371
Other current liabilities	12,892	39,939
Total current liabilities	1,322,742	2,915,436
Long term liabilities
Lease liability long term	11,108
Total Liabilities	1,333,850	2,915,436
Commitments and contingencies (note 13)
Stockholders' equity
Preferred stock - $0.001 par value; 10,000,000 shares authorized; 671 and 2,379 shares issued and outstanding as of December 31, 2019 and December 31, 2018, respectively	1	2
Additional paid-in capital - Series B convertible preferred stock	670,999	2,378,997
Common stock - $0.18 par value; 175,000,000 shares authorized, and 9,130,984 and 5,846,552 shares issued and outstanding, as of December 31, 2019 and December 31, 2018, respectively	1,643,565	1,052,372
Additional paid-in capital	104,912,480	82,204,902
Accumulated deficit	(94,071,040)	(76,831,263)
Total Stockholders' Equity	13,156,005	8,805,010
Total Liabilities and Stockholders' Equity	$ 14,489,855	$ 11,720,446